The impact of immuno-aging on SARS-CoV-2 vaccine development

The SARS-CoV-2 pandemic has almost 56 million confirmed cases resulting in over 1.3 million deaths as of November 2020. This infection has proved more deadly to older adults (those >65 years of age) and those with immunocompromising conditions. The worldwide population aged 65 years and older is...

Descripción completa

Detalles Bibliográficos
Autores principales: Connors, Jennifer, Bell, Matthew R., Marcy, Jennifer, Kutzler, Michele, Haddad, Elias K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7875765/
https://www.ncbi.nlm.nih.gov/pubmed/33569701
http://dx.doi.org/10.1007/s11357-021-00323-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7875765/
https://www.ncbi.nlm.nih.gov/pubmed/33569701
http://dx.doi.org/10.1007/s11357-021-00323-3

Ejemplares similares